{"title":"Nicotinic acid/laropiprant: a new lipid-modifying therapy","authors":"Steve Chaplin MSc, MRPharmS, Marc Evans MRCP, MD","doi":"10.1002/fps.44","DOIUrl":null,"url":null,"abstract":"<p>Cardiovascular disease (CVD) is a leading cause of death in the UK.<sup>1</sup> Blood choleserol levels are a key risk factor for CVD, and can be modified by both drug treatment and lifestyle changes. In this article, Steve Chaplin considers the available clinical data on a new lipid-modifying therapy, a modified-release formulation of nicotinic acid and laropiprant; and Marc Evans comments on its potential contribution to reducing the risk of CVD. Copyright © 2009 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"10 1","pages":"20-23"},"PeriodicalIF":0.0000,"publicationDate":"2009-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.44","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cardiovascular disease (CVD) is a leading cause of death in the UK.1 Blood choleserol levels are a key risk factor for CVD, and can be modified by both drug treatment and lifestyle changes. In this article, Steve Chaplin considers the available clinical data on a new lipid-modifying therapy, a modified-release formulation of nicotinic acid and laropiprant; and Marc Evans comments on its potential contribution to reducing the risk of CVD. Copyright © 2009 John Wiley & Sons, Ltd.
烟酸/laropiprant:一种新的脂质调节疗法
在英国，心血管疾病(CVD)是导致死亡的主要原因。1血液中的胆固醇水平是CVD的一个关键危险因素，可以通过药物治疗和生活方式的改变来改变。在本文中，Steve Chaplin考虑了一种新的脂质修饰疗法的现有临床数据，一种烟酸和laropiprant的修饰释放制剂;马克·埃文斯评论了它对降低心血管疾病风险的潜在贡献。版权所有©2009 John Wiley &儿子,有限公司
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
